MAM
GH icon

Meeder Asset Management’s Guardant Health GH Stock Holding History

Meeder Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.5K Sell
30
-51
-63% -$5.55K ﹤0.01% 856
2026
Q1 		$7.48K Sell
81
-7,805
-99% -$784K ﹤0.01% 759
2025
Q4 		$805K Buy
7,886
+7,843
+18,240% +$702K 0.04% 172
2025
Q3 		$2.69K Sell
43
-3
-7% -$163 ﹤0.01% 761
2025
Q2 		$2.39K Buy
46
+2
+5% +$89 ﹤0.01% 803
2025
Q1 		$1.87K Sell
44
-32
-42% -$1.38K ﹤0.01% 870
2024
Q4 		$2.32K Buy
+76
New +$2.14K ﹤0.01% 884
2024
Q3 		– Sell
-80
Closed -$2.31K – 888
2024
Q2 		$2.31K Buy
+80
New +$1.86K ﹤0.01% 839
2022
Q4 		– Sell
-1
Closed – – 1259
2022
Q3 		$0 Sell
1
-3
-75% -$154 ﹤0.01% 2225
2022
Q2 		$0 Sell
4
-7
-64% -$347 ﹤0.01% 2269
2022
Q1 		$1K Buy
+11
New +$753 ﹤0.01% 2184
2021
Q4 		– Sell
-52
Closed -$7K – 1627
2021
Q3 		$7K Sell
52
-58
-53% -$6.89K ﹤0.01% 1797
2021
Q2 		$14K Sell
110
-119
-52% -$16K ﹤0.01% 1578
2021
Q1 		$38K Buy
229
+206
+896% +$31.1K ﹤0.01% 1188
2020
Q4 		$3K Buy
23
+1
+5% +$115 ﹤0.01% 1359
2020
Q3 		$2K Sell
22
-85
-79% -$7.78K ﹤0.01% 1837
2020
Q2 		$9K Buy
107
+77
+257% +$6.2K ﹤0.01% 1345
2020
Q1 		$2K Buy
30
+3
+11% +$230 ﹤0.01% 2082
2019
Q4 		$2K Buy
27
+5
+23% +$360 ﹤0.01% 2009
2019
Q3 		$1K Buy
+22
New +$1.94K ﹤0.01% 2055

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Meeder Asset Management's GH Position: Q2 2026 in Review

Meeder Asset Management reduced its Guardant Health (GH) stake by 63% in Q2 2026, selling an estimated $5.55K and leaving 30 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Meeder Asset Management first reported a position in GH in Q3 2019 and has held it in 20 quarters since. The position peaked at $805K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Meeder Asset Management held 30 shares of Guardant Health worth $4.5K as of Q2 2026.
  • Meeder Asset Management sold 51 Guardant Health shares in Q2 2026, an estimated $5.55K.
  • Guardant Health made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #856 holding.
  • Meeder Asset Management first reported a position in Guardant Health in Q3 2019 and has held it in 20 quarters since.
  • Meeder Asset Management's Guardant Health position peaked at $805K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.